[1]
Ликстанов, М.И. et al. 2023. EFFICACY AND SAFETY OF REGDANVIMAB THERAPY IN MODERATE COURSE OF COVID-19. Medicine in Kuzbass. 22, 1 (Feb. 2023), 17–21. DOI:https://doi.org/10.24412/2687-0053-2023-1-17-21.